CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 99 filers reported holding CUE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 9.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $86,000 | -56.8% | 17,616 | 0.0% | 0.00% | – |
Q4 2021 | $199,000 | -21.3% | 17,616 | +1.6% | 0.00% | – |
Q3 2021 | $253,000 | +25.2% | 17,334 | 0.0% | 0.00% | – |
Q2 2021 | $202,000 | +13.5% | 17,334 | +18.9% | 0.00% | – |
Q1 2021 | $178,000 | -2.2% | 14,579 | 0.0% | 0.00% | – |
Q4 2020 | $182,000 | -16.9% | 14,579 | 0.0% | 0.00% | – |
Q3 2020 | $219,000 | -38.1% | 14,579 | +1.0% | 0.00% | -100.0% |
Q2 2020 | $354,000 | – | 14,439 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corriente Advisors, LLC | 1,915,219 | $23,959,000 | 5.70% |
Prosight Management, LP | 906,569 | $11,341,000 | 5.24% |
P.A.W. CAPITAL CORP | 140,000 | $1,751,000 | 1.54% |
Voss Capital, LLC | 220,714 | $2,761,000 | 1.39% |
Robertson Stephens Wealth Management, LLC | 484,000 | $6,054,000 | 1.26% |
Slate Path Capital LP | 1,483,619 | $18,560,000 | 1.00% |
Nantahala Capital Management | 2,506,772 | $31,360,000 | 0.97% |
PRECEPT MANAGEMENT LLC | 150,000 | $1,877,000 | 0.76% |
SANDERS MORRIS HARRIS LLC | 193,591 | $2,449,000 | 0.56% |
Rock Creek Group, LP | 100,014 | $1,251,000 | 0.51% |